Roivant Sciences (ROIV) Tax Rate (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Tax Rate came in at 4.87% in Q4 2025, down 1021.0% YoY from 0.53% in Q4 2024, and down 10.65% on a QoQ basis from 4.4% in Q3 2025.
Analysis
Roivant Sciences (ROIV) Tax Rate (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 6 years of Tax Rate data on file, last reported at 4.87% in Q4 2025.
- Quarterly Tax Rate fell 1021.0% year-over-year to 4.87% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.3% (down 188.0% YoY) and the FY2026 annual result came in at 50.39%, down 4333.0% from the prior year.
- Tax Rate eased to 4.87% in Q4 2025, from 4.4% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 5.34% in Q4 2024 to a low of 60.91% in Q2 2024.
- A 5-year average of 5.1% and a median of 0.86% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate slumped 6037 bps — and 2025, when it soared 5918 bps.
- Tracing ROIV's Tax Rate over 5 years: stood at 0.08% in 2021, then sank by 921 bps to 0.86% in 2022, then soared by 162 bps to 0.53% in 2023, then soared by 910 bps to 5.34% in 2024, then slumped by 191 bps to 4.87% in 2025.
- The last three Tax Rate figures came in at 4.87% (Q4 2025), 4.4% (Q3 2025), and 1.73% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -16.71% |
| 10 | Roivant Sciences | 24.78 Bn | 24.78 Bn | 1.16 Mn | 1.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34% |
| Dec 31, 2025 | -4.87% |
| Sep 30, 2025 | -4.40% |
| Jun 30, 2025 | -1.73% |
| Dec 31, 2024 | 5.34% |
| Sep 30, 2024 | -5.55% |
| Jun 30, 2024 | -60.91% |
| Dec 31, 2023 | 0.53% |
| Sep 30, 2023 | -1.34% |
| Jun 30, 2023 | -0.54% |
| Dec 31, 2022 | -0.86% |
| Sep 30, 2022 | -0.69% |
| Jun 30, 2022 | -1.14% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.18% |
| Jun 30, 2021 | -0.09% |
| Dec 31, 2020 | 0.08% |
| Sep 30, 2020 | -1.35% |
| Jun 30, 2020 | -18.07% |